menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Matthew S. Davids, MMSc, MD
Matthew S. Davids, MMSc, MD
  • Director, Clinical Research, Division of Lymphoma,
  • Dana-Farber Cancer Institute
  • Associate Professor of Medicine
  • Harvard Medical School, Boston, Massachusetts
Matt Davids received his AB (artium baccalaureus) cum laude in Chemistry from Harvard College, his MD cum laude from Yale University School of Medicine, and his MMSc (Masters in Medical Sciences) degree from Harvard Medical School. He trained in internal medicine at New York Presbyterian Weill-Cornell Medical Center and Memorial Sloan Kettering Cancer Center in New York City before returning to his native Boston to complete his fellowship in hematology and oncology in the Dana-Farber/Brigham & Women's/Massachusetts General Hospital Program. He did his postdoctoral laboratory training in the Letai Lab under the mentorship of Dr. Anthony Letai, where he showed that decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in CLL and that priming may predict response to therapy in CLL. In 2011, Dr. Davids joined the faculty of Harvard Medical School and Dana-Farber Cancer Institute, where he is now an Assistant Professor of Medicine and is the Associate Director of the CLL Center. He is a leading clinical investigator on the international clinical trials of the new Bcl-2 inhibitor venetoclax. He has pioneered the use of checkpoint blockade to treat patients with hematologic malignancies who relapse after allogeneic stem cell transplantation. He has also developed several investigator-initiated clinical trials of novel agents for patients with CLL, and uses the BH3 profiling technique to study samples from these trials to help predict response to therapy and to help understand reasons why patients become resistant. In his spare time, Dr. Davids loves to spend time with his wife and two kids, cycle each year in the Pan-Mass Challenge, run, play squash, listen to a diverse array of music, and travel.
Schedule29 Mar 2024